Posted inBiotechnology
Posted inBiotechnology
Regeneron anticoagulant bests enoxaparin, matches Eliquis in phase 2 trial
A pair of Regeneron’s monoclonal antibodies have held their own against a commonly used anticoagulant in a phase 2 trial,…





















